-
Carbapenemase Gene Transmission in CREC
2026-09-21
Chen et al. characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining plasmid elimination, PCR, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR genotyping. The study shows that blaNDM-1 was frequently plasmid-associated and readily transferable, linking multidrug resistance with both horizontal gene mobility and possible clonal dissemination.
-
HNF4A-AS1 and Sorafenib Resistance in HCC
2026-09-20
This Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma through METTL3/YTHDF3-dependent control of DECR1 and PUFA metabolism. Its integrated use of public datasets, lipidomics, molecular assays, organoids, and xenografts provides a mechanistic framework for studying metabolic drivers of drug resistance.
-
Chloramphenicol for Plasmid Selection
2026-09-19
Build more reproducible plasmid-selection assays with a defined 50S ribosomal inhibitor, concentration strategy, and confirmation workflow. Learn how Chloramphenicol can complement plasmid-transfer studies without substituting for PCR or genotypic resistance analysis.
-
Pronase E for Ferroptosis Proteomics
2026-09-18
Learn how to use Pronase E as a broad-spectrum protease mixture for target-engagement, surface-protein, and proteomic workflows inspired by ferroptosis research. The guide emphasizes fresh reagent preparation, controlled digestion, assay-specific controls, and troubleshooting for reproducible results.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-18
This review presents tumor hypoxia and immunometabolism as a coupled system in which oxygen limitation, nutrient competition, and immune-cell dysfunction reinforce an immunosuppressive tumor microenvironment. Its main practical contribution is a framework for connecting HIF signaling and metabolic adaptation with immune evasion, while identifying opportunities and limitations for metabolism- and hypoxia-directed therapeutic research.
-
Chloramphenicol: Mechanism and Plasmid Selection
2026-09-17
Chloramphenicol is a bacterial 50S ribosomal inhibitor used in molecular biology and plasmid selection assays. Its documented concentration, solubility, and storage parameters support reproducible workflows, while recent plasmid-transmission data show why antibiotic selection should not be treated as a substitute for genotypic confirmation.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Assays
2026-09-17
Build reproducible plasmid workflows for AML gene-regulation studies, from cloning and sequence verification to robust-cell-line transfection. The ApexPrep DNA Plasmid Miniprep Kit combines alkaline lysis with membrane-based cleanup to support high- and low-copy constructs in one streamlined preparation.
-
Obeticholic Acid: An FXR Strategy for Liver Fibrosis
2026-09-16
A mechanism-focused guide to using Obeticholic Acid as an FXR probe in liver fibrosis, bile acid, inflammation, and portal-pressure research, with practical validation strategies and translational guardrails.
-
MK-8745: Reading Aurora A Biology in Cancer Models
2026-09-16
MK-8745 is a potent, selective Aurora A inhibitor for connecting mitotic arrest with apoptosis, genotype, and tumor pathology. This article presents an evidence-based assay framework for interpreting Aurora A dependence across cell-based, lymphoma, xenograft, and retinoblastoma research.
-
EZ Cap™ Cy5 EGFP mRNA: Delivery Workflows
2026-09-15
Build a dual-readout mRNA delivery assay that separates cellular uptake from productive translation. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports macrophage-targeted nanoparticle validation, live imaging, flow cytometry, and quantitative formulation troubleshooting.
-
Merimepodib (VX-497): Assay Reliability Guide
2026-09-15
This scenario-based guide explains how Merimepodib (VX-497), SKU B1112, can support reproducible cell proliferation, viability, immunosuppression, and antiviral research. It connects IMPDH biology with practical controls for dosing, solvent compatibility, interpretation, and product selection.
-
P2RX1 and Mitochondrial Apoptosis in Ph+ ALL
2026-09-14
Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking calcium/CaMKII activity to mitochondrial dysfunction and suppression of PI3K/Akt signaling. The study provides a mechanistic framework for interpreting apoptosis assays in Ph+ ALL, while also highlighting the need to distinguish phosphatidylserine exposure from broader mitochondrial and viability measurements.
-
Plastid DNA Breaks in Arabidopsis: DEtail-seq Insights
2026-09-14
The reference study uses DNA end tailing and sequencing (DEtail-seq) to define how plastid DNA breaks vary across Arabidopsis development, repair backgrounds, and environmental conditions. Its findings connect tissue age, ribosomal DNA vulnerability, R-loops, reactive oxygen species, and repair capacity while showing why direct DNA-break mapping should be paired with, rather than replaced by, oxidative-stress measurements.
-
Dinaciclib (SCH727965): CDK Mechanism & Use
2026-09-13
Dinaciclib (SCH727965) is a potent multi-CDK inhibitor for cancer research focused on cell-cycle control, Rb phosphorylation inhibition, and apoptosis induction in cancer cells. Its strongest evidence supports biochemical CDK inhibition, molecular response assays, and ovarian-cancer xenograft research, while tissue-boundary applications remain a mechanistic hypothesis rather than a validated indication.
-
Biotin-HPDP: Reliable Thiol Labeling
2026-09-12
Learn how Biotin-HPDP (SKU A8008) can add reversible thiol-specific protein labeling to viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, protocol controls, streptavidin detection, interpretation, and practical vendor selection.